Completed PHASE2 INTERVENTIONAL NCT00199823

Autologous Stem Cell Transplantation in Acute Myocardial Infarction

Sponsor: Oslo University Hospital

Conditions Acute Anterior Wall Myocardial Infarction

Interventions Intracoronary aotologous stem cell transplantation

Updated 5 times since 2017 Last updated: Jul 3, 2011 Started: Sep 30, 2003 Completion: May 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00199823, this PHASE2 trial focuses on Acute Anterior Wall Myocardial Infarction and remains completed. Sponsored by Oslo University Hospital, it has been updated 5 times since 2003, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital
Ullevaal University Hospital
University of Oslo

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway